Bristol-Myers Squibb Co 345 Park Ave, New York, NY 10154, USA
Posted on 12/01/2016 / 177
Listing Types : Specific Chart Trade
Item Type : Pharmaceuticals
Location : USA East

Bristol-Myers Squibb Co NYSE: BMY
Health Care : Pharmaceuticals | Large Cap Blend

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company’s pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience; cardiovascular, and neuroscience. Its late-stage investigational compounds that are in Phase III clinical trials include Beclabuvir, BMS-663068 and Prostvac.

Chart play at below $53.00 leveling off now & could gap up again or run.

TAGS
Features
Commodities
Forex
Option
Physical Metal
Stock
Reviews
3
Total Score 1 REVIEW
(Ratings Rules - One Star Equals No Rating) Strong Buy: Buy : Hold: Unsure : Sell: Strong Sell :
Leave a review
(Ratings Rules - One Star Equals No Rating) Strong Buy: Buy : Hold: Unsure : Sell: Strong Sell :